Multiple Sclerosis is a debilitating neurologic disease that is thought to be caused by destruction of the myelin sheaths (fatty protective insulation) around axons of the brain and spinal cord. Loss of myelin impacts the ability of these tissues to conduct signals and the inflammatory process can lead to scarring resulting in a broad range of symptoms. This myelin damage appears to be related primarily to an auto-immune dysfunction, but there also appears to be environmental and genetic factors involved.
There is no known cure for the physical and cognitive defects associated with chronic Multiple Sclerosis. Many investigators are looking at using the regenerative properties of cell therapy to mitigate the impact of Multiple Sclerosis on the nervous system.
Stem Cells can be used to harvest autologous mysenchymal stem cells through a mini-liposuction procedure. The cells are separated from fat tissue, tested for bacteria and then administered intravenously. The main goals of stem cell therapy are remyelination to repair damage and immunomodulation to prevent future damage.
Each person who undergoes stem cell therapy may have a different result. Disability can be reversed, pain abated, and future attacks warded off. This may be more successful in some than in others.
Some common improvements following treatment include:
• improvement in cognition
• almost complete reduction in spasticity
• improved energy level
• decrease in pain